Jeisys Medical Successfully Concludes 2025 IMCAS PARIS
- Author
- Date
- 2025-02-01
- Views
- 730
Strengthening Global Brand Presence and Showcasing Innovative Technologies
Networking Event Held with Brazilian KOLs, Dr. Rox Anderson, and Dr. Dieter Manstein
Jeisys Medical successfully participated in the IMCAS World Congress 2025, held at the Palais des Congrès in Paris from January 30 to February 1.
Celebrating its 21st anniversary this year, Jeisys Medical attended IMCAS PARIS for the first time since the COVID-19 pandemic, showcasing its research achievements to a global audience. The company presented its flagship products, including Density, LinearZ, Potenza, Ultracel Q+, and CellecV, while reinforcing its identity as a global brand under the slogan "Tailored Excellence." The booth attracted significant attention by introducing customized and differentiated aesthetic solutions.
On the first day of the event, January 30, Jeisys Medical hosted a networking dinner with Key Opinion Leaders (KOLs) from Brazil and Japan. The event featured influential figures such as Dr. Rox Anderson, Dr. Fernanda Sakamoto, and Dr. Dieter Manstein, along with 10 prominent Brazilian KOLs and distinguished Japanese medical professionals, fostering valuable exchanges.
On January 31, during the academic presentations, the clinical success achieved using LinearZ was highlighted, drawing significant interest from attendees.
A Jeisys Medical representative stated, “At IMCAS PARIS, we were able to showcase our brand’s history through a dedicated exhibition booth, highlighting Jeisys Medical’s technological excellence to key opinion leaders and industry professionals. Moving forward, we will continue participating in global conferences such as IMCAS AMERICAS and IMCAS ASIA to further strengthen our presence in the international market.”
Held from January 30 to February 1, IMCAS PARIS 2025 is one of the world's leading medical aesthetics exhibitions, bringing together plastic surgeons, dermatologists, and medical aesthetics professionals to share the latest technologies and research advancements.
